Who stays in medication treatment for opioid use disorder? A national study of outpatient specialty treatment settings
Maintenance treatments with medications for opioid use disorder (MOUD) are highly effective at reducing overdose risk while patients remain in care. However, few patients initiate medication and retention remains a critical challenge across settings. Much remains to be learned about individual and s...
Ausführliche Beschreibung
Gespeichert in:
| Autor*in: |
Krawczyk, Noa [verfasserIn] |
|---|
| Format: |
E-Artikel |
|---|---|
| Sprache: |
Englisch |
| Erschienen: |
2021 |
|---|
| Übergeordnetes Werk: |
Enthalten in: Local Control After Stereotactic Radiosurgery (SRS) for Brain Metastases (BM) in Melanoma Patients With and Without BRAF Mutation and Treatment - 2013, Amsterdam [u.a.] |
|---|---|
| Übergeordnetes Werk: |
volume:126 ; year:2021 ; pages:0 |
| Links: |
|---|
| DOI / URN: |
10.1016/j.jsat.2021.108329 |
|---|
| Katalog-ID: |
ELV054325544 |
|---|
| LEADER | 01000caa a22002652 4500 | ||
|---|---|---|---|
| 001 | ELV054325544 | ||
| 003 | DE-627 | ||
| 005 | 20230624210427.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 210910s2021 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1016/j.jsat.2021.108329 |2 doi | |
| 028 | 5 | 2 | |a /cbs_pica/cbs_olc/import_discovery/elsevier/einzuspielen/GBV00000000001417.pica |
| 035 | |a (DE-627)ELV054325544 | ||
| 035 | |a (ELSEVIER)S0740-5472(21)00055-6 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 082 | 0 | 4 | |a 610 |q VZ |
| 082 | 0 | 4 | |a 610 |q VZ |
| 084 | |a 44.40 |2 bkl | ||
| 100 | 1 | |a Krawczyk, Noa |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Who stays in medication treatment for opioid use disorder? A national study of outpatient specialty treatment settings |
| 264 | 1 | |c 2021 | |
| 336 | |a nicht spezifiziert |b zzz |2 rdacontent | ||
| 337 | |a nicht spezifiziert |b z |2 rdamedia | ||
| 338 | |a nicht spezifiziert |b zu |2 rdacarrier | ||
| 520 | |a Maintenance treatments with medications for opioid use disorder (MOUD) are highly effective at reducing overdose risk while patients remain in care. However, few patients initiate medication and retention remains a critical challenge across settings. Much remains to be learned about individual and structural factors that influence successful retention, especially among populations dispensed MOUD in outpatient settings. | ||
| 700 | 1 | |a Williams, Arthur Robin |4 oth | |
| 700 | 1 | |a Saloner, Brendan |4 oth | |
| 700 | 1 | |a Cerdá, Magdalena |4 oth | |
| 773 | 0 | 8 | |i Enthalten in |n Elsevier Science |t Local Control After Stereotactic Radiosurgery (SRS) for Brain Metastases (BM) in Melanoma Patients With and Without BRAF Mutation and Treatment |d 2013 |g Amsterdam [u.a.] |w (DE-627)ELV011527242 |
| 773 | 1 | 8 | |g volume:126 |g year:2021 |g pages:0 |
| 856 | 4 | 0 | |u https://doi.org/10.1016/j.jsat.2021.108329 |3 Volltext |
| 912 | |a GBV_USEFLAG_U | ||
| 912 | |a GBV_ELV | ||
| 912 | |a SYSFLAG_U | ||
| 912 | |a SSG-OLC-PHA | ||
| 912 | |a SSG-OPC-PHA | ||
| 912 | |a GBV_ILN_20 | ||
| 912 | |a GBV_ILN_30 | ||
| 912 | |a GBV_ILN_40 | ||
| 936 | b | k | |a 44.40 |j Pharmazie |j Pharmazeutika |q VZ |
| 951 | |a AR | ||
| 952 | |d 126 |j 2021 |h 0 | ||
| author_variant |
n k nk |
|---|---|
| matchkey_str |
krawczyknoawilliamsarthurrobinsalonerbre:2021----:hsasneiainramnfrpodsdsreaainltdootain |
| hierarchy_sort_str |
2021 |
| bklnumber |
44.40 |
| publishDate |
2021 |
| allfields |
10.1016/j.jsat.2021.108329 doi /cbs_pica/cbs_olc/import_discovery/elsevier/einzuspielen/GBV00000000001417.pica (DE-627)ELV054325544 (ELSEVIER)S0740-5472(21)00055-6 DE-627 ger DE-627 rakwb eng 610 VZ 610 VZ 44.40 bkl Krawczyk, Noa verfasserin aut Who stays in medication treatment for opioid use disorder? A national study of outpatient specialty treatment settings 2021 nicht spezifiziert zzz rdacontent nicht spezifiziert z rdamedia nicht spezifiziert zu rdacarrier Maintenance treatments with medications for opioid use disorder (MOUD) are highly effective at reducing overdose risk while patients remain in care. However, few patients initiate medication and retention remains a critical challenge across settings. Much remains to be learned about individual and structural factors that influence successful retention, especially among populations dispensed MOUD in outpatient settings. Williams, Arthur Robin oth Saloner, Brendan oth Cerdá, Magdalena oth Enthalten in Elsevier Science Local Control After Stereotactic Radiosurgery (SRS) for Brain Metastases (BM) in Melanoma Patients With and Without BRAF Mutation and Treatment 2013 Amsterdam [u.a.] (DE-627)ELV011527242 volume:126 year:2021 pages:0 https://doi.org/10.1016/j.jsat.2021.108329 Volltext GBV_USEFLAG_U GBV_ELV SYSFLAG_U SSG-OLC-PHA SSG-OPC-PHA GBV_ILN_20 GBV_ILN_30 GBV_ILN_40 44.40 Pharmazie Pharmazeutika VZ AR 126 2021 0 |
| spelling |
10.1016/j.jsat.2021.108329 doi /cbs_pica/cbs_olc/import_discovery/elsevier/einzuspielen/GBV00000000001417.pica (DE-627)ELV054325544 (ELSEVIER)S0740-5472(21)00055-6 DE-627 ger DE-627 rakwb eng 610 VZ 610 VZ 44.40 bkl Krawczyk, Noa verfasserin aut Who stays in medication treatment for opioid use disorder? A national study of outpatient specialty treatment settings 2021 nicht spezifiziert zzz rdacontent nicht spezifiziert z rdamedia nicht spezifiziert zu rdacarrier Maintenance treatments with medications for opioid use disorder (MOUD) are highly effective at reducing overdose risk while patients remain in care. However, few patients initiate medication and retention remains a critical challenge across settings. Much remains to be learned about individual and structural factors that influence successful retention, especially among populations dispensed MOUD in outpatient settings. Williams, Arthur Robin oth Saloner, Brendan oth Cerdá, Magdalena oth Enthalten in Elsevier Science Local Control After Stereotactic Radiosurgery (SRS) for Brain Metastases (BM) in Melanoma Patients With and Without BRAF Mutation and Treatment 2013 Amsterdam [u.a.] (DE-627)ELV011527242 volume:126 year:2021 pages:0 https://doi.org/10.1016/j.jsat.2021.108329 Volltext GBV_USEFLAG_U GBV_ELV SYSFLAG_U SSG-OLC-PHA SSG-OPC-PHA GBV_ILN_20 GBV_ILN_30 GBV_ILN_40 44.40 Pharmazie Pharmazeutika VZ AR 126 2021 0 |
| allfields_unstemmed |
10.1016/j.jsat.2021.108329 doi /cbs_pica/cbs_olc/import_discovery/elsevier/einzuspielen/GBV00000000001417.pica (DE-627)ELV054325544 (ELSEVIER)S0740-5472(21)00055-6 DE-627 ger DE-627 rakwb eng 610 VZ 610 VZ 44.40 bkl Krawczyk, Noa verfasserin aut Who stays in medication treatment for opioid use disorder? A national study of outpatient specialty treatment settings 2021 nicht spezifiziert zzz rdacontent nicht spezifiziert z rdamedia nicht spezifiziert zu rdacarrier Maintenance treatments with medications for opioid use disorder (MOUD) are highly effective at reducing overdose risk while patients remain in care. However, few patients initiate medication and retention remains a critical challenge across settings. Much remains to be learned about individual and structural factors that influence successful retention, especially among populations dispensed MOUD in outpatient settings. Williams, Arthur Robin oth Saloner, Brendan oth Cerdá, Magdalena oth Enthalten in Elsevier Science Local Control After Stereotactic Radiosurgery (SRS) for Brain Metastases (BM) in Melanoma Patients With and Without BRAF Mutation and Treatment 2013 Amsterdam [u.a.] (DE-627)ELV011527242 volume:126 year:2021 pages:0 https://doi.org/10.1016/j.jsat.2021.108329 Volltext GBV_USEFLAG_U GBV_ELV SYSFLAG_U SSG-OLC-PHA SSG-OPC-PHA GBV_ILN_20 GBV_ILN_30 GBV_ILN_40 44.40 Pharmazie Pharmazeutika VZ AR 126 2021 0 |
| allfieldsGer |
10.1016/j.jsat.2021.108329 doi /cbs_pica/cbs_olc/import_discovery/elsevier/einzuspielen/GBV00000000001417.pica (DE-627)ELV054325544 (ELSEVIER)S0740-5472(21)00055-6 DE-627 ger DE-627 rakwb eng 610 VZ 610 VZ 44.40 bkl Krawczyk, Noa verfasserin aut Who stays in medication treatment for opioid use disorder? A national study of outpatient specialty treatment settings 2021 nicht spezifiziert zzz rdacontent nicht spezifiziert z rdamedia nicht spezifiziert zu rdacarrier Maintenance treatments with medications for opioid use disorder (MOUD) are highly effective at reducing overdose risk while patients remain in care. However, few patients initiate medication and retention remains a critical challenge across settings. Much remains to be learned about individual and structural factors that influence successful retention, especially among populations dispensed MOUD in outpatient settings. Williams, Arthur Robin oth Saloner, Brendan oth Cerdá, Magdalena oth Enthalten in Elsevier Science Local Control After Stereotactic Radiosurgery (SRS) for Brain Metastases (BM) in Melanoma Patients With and Without BRAF Mutation and Treatment 2013 Amsterdam [u.a.] (DE-627)ELV011527242 volume:126 year:2021 pages:0 https://doi.org/10.1016/j.jsat.2021.108329 Volltext GBV_USEFLAG_U GBV_ELV SYSFLAG_U SSG-OLC-PHA SSG-OPC-PHA GBV_ILN_20 GBV_ILN_30 GBV_ILN_40 44.40 Pharmazie Pharmazeutika VZ AR 126 2021 0 |
| allfieldsSound |
10.1016/j.jsat.2021.108329 doi /cbs_pica/cbs_olc/import_discovery/elsevier/einzuspielen/GBV00000000001417.pica (DE-627)ELV054325544 (ELSEVIER)S0740-5472(21)00055-6 DE-627 ger DE-627 rakwb eng 610 VZ 610 VZ 44.40 bkl Krawczyk, Noa verfasserin aut Who stays in medication treatment for opioid use disorder? A national study of outpatient specialty treatment settings 2021 nicht spezifiziert zzz rdacontent nicht spezifiziert z rdamedia nicht spezifiziert zu rdacarrier Maintenance treatments with medications for opioid use disorder (MOUD) are highly effective at reducing overdose risk while patients remain in care. However, few patients initiate medication and retention remains a critical challenge across settings. Much remains to be learned about individual and structural factors that influence successful retention, especially among populations dispensed MOUD in outpatient settings. Williams, Arthur Robin oth Saloner, Brendan oth Cerdá, Magdalena oth Enthalten in Elsevier Science Local Control After Stereotactic Radiosurgery (SRS) for Brain Metastases (BM) in Melanoma Patients With and Without BRAF Mutation and Treatment 2013 Amsterdam [u.a.] (DE-627)ELV011527242 volume:126 year:2021 pages:0 https://doi.org/10.1016/j.jsat.2021.108329 Volltext GBV_USEFLAG_U GBV_ELV SYSFLAG_U SSG-OLC-PHA SSG-OPC-PHA GBV_ILN_20 GBV_ILN_30 GBV_ILN_40 44.40 Pharmazie Pharmazeutika VZ AR 126 2021 0 |
| language |
English |
| source |
Enthalten in Local Control After Stereotactic Radiosurgery (SRS) for Brain Metastases (BM) in Melanoma Patients With and Without BRAF Mutation and Treatment Amsterdam [u.a.] volume:126 year:2021 pages:0 |
| sourceStr |
Enthalten in Local Control After Stereotactic Radiosurgery (SRS) for Brain Metastases (BM) in Melanoma Patients With and Without BRAF Mutation and Treatment Amsterdam [u.a.] volume:126 year:2021 pages:0 |
| format_phy_str_mv |
Article |
| bklname |
Pharmazie Pharmazeutika |
| institution |
findex.gbv.de |
| dewey-raw |
610 |
| isfreeaccess_bool |
false |
| container_title |
Local Control After Stereotactic Radiosurgery (SRS) for Brain Metastases (BM) in Melanoma Patients With and Without BRAF Mutation and Treatment |
| authorswithroles_txt_mv |
Krawczyk, Noa @@aut@@ Williams, Arthur Robin @@oth@@ Saloner, Brendan @@oth@@ Cerdá, Magdalena @@oth@@ |
| publishDateDaySort_date |
2021-01-01T00:00:00Z |
| hierarchy_top_id |
ELV011527242 |
| dewey-sort |
3610 |
| id |
ELV054325544 |
| language_de |
englisch |
| fullrecord |
<?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>01000caa a22002652 4500</leader><controlfield tag="001">ELV054325544</controlfield><controlfield tag="003">DE-627</controlfield><controlfield tag="005">20230624210427.0</controlfield><controlfield tag="007">cr uuu---uuuuu</controlfield><controlfield tag="008">210910s2021 xx |||||o 00| ||eng c</controlfield><datafield tag="024" ind1="7" ind2=" "><subfield code="a">10.1016/j.jsat.2021.108329</subfield><subfield code="2">doi</subfield></datafield><datafield tag="028" ind1="5" ind2="2"><subfield code="a">/cbs_pica/cbs_olc/import_discovery/elsevier/einzuspielen/GBV00000000001417.pica</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-627)ELV054325544</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(ELSEVIER)S0740-5472(21)00055-6</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-627</subfield><subfield code="b">ger</subfield><subfield code="c">DE-627</subfield><subfield code="e">rakwb</subfield></datafield><datafield tag="041" ind1=" " ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="082" ind1="0" ind2="4"><subfield code="a">610</subfield><subfield code="q">VZ</subfield></datafield><datafield tag="082" ind1="0" ind2="4"><subfield code="a">610</subfield><subfield code="q">VZ</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="a">44.40</subfield><subfield code="2">bkl</subfield></datafield><datafield tag="100" ind1="1" ind2=" "><subfield code="a">Krawczyk, Noa</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Who stays in medication treatment for opioid use disorder? A national study of outpatient specialty treatment settings</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="c">2021</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">zzz</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">z</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">zu</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="520" ind1=" " ind2=" "><subfield code="a">Maintenance treatments with medications for opioid use disorder (MOUD) are highly effective at reducing overdose risk while patients remain in care. However, few patients initiate medication and retention remains a critical challenge across settings. Much remains to be learned about individual and structural factors that influence successful retention, especially among populations dispensed MOUD in outpatient settings.</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Williams, Arthur Robin</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Saloner, Brendan</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Cerdá, Magdalena</subfield><subfield code="4">oth</subfield></datafield><datafield tag="773" ind1="0" ind2="8"><subfield code="i">Enthalten in</subfield><subfield code="n">Elsevier Science</subfield><subfield code="t">Local Control After Stereotactic Radiosurgery (SRS) for Brain Metastases (BM) in Melanoma Patients With and Without BRAF Mutation and Treatment</subfield><subfield code="d">2013</subfield><subfield code="g">Amsterdam [u.a.]</subfield><subfield code="w">(DE-627)ELV011527242</subfield></datafield><datafield tag="773" ind1="1" ind2="8"><subfield code="g">volume:126</subfield><subfield code="g">year:2021</subfield><subfield code="g">pages:0</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">https://doi.org/10.1016/j.jsat.2021.108329</subfield><subfield code="3">Volltext</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_USEFLAG_U</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ELV</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SYSFLAG_U</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SSG-OLC-PHA</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SSG-OPC-PHA</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_20</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_30</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_40</subfield></datafield><datafield tag="936" ind1="b" ind2="k"><subfield code="a">44.40</subfield><subfield code="j">Pharmazie</subfield><subfield code="j">Pharmazeutika</subfield><subfield code="q">VZ</subfield></datafield><datafield tag="951" ind1=" " ind2=" "><subfield code="a">AR</subfield></datafield><datafield tag="952" ind1=" " ind2=" "><subfield code="d">126</subfield><subfield code="j">2021</subfield><subfield code="h">0</subfield></datafield></record></collection>
|
| author |
Krawczyk, Noa |
| spellingShingle |
Krawczyk, Noa ddc 610 bkl 44.40 Who stays in medication treatment for opioid use disorder? A national study of outpatient specialty treatment settings |
| authorStr |
Krawczyk, Noa |
| ppnlink_with_tag_str_mv |
@@773@@(DE-627)ELV011527242 |
| format |
electronic Article |
| dewey-ones |
610 - Medicine & health |
| delete_txt_mv |
keep |
| author_role |
aut |
| collection |
elsevier |
| remote_str |
true |
| illustrated |
Not Illustrated |
| topic_title |
610 VZ 44.40 bkl Who stays in medication treatment for opioid use disorder? A national study of outpatient specialty treatment settings |
| topic |
ddc 610 bkl 44.40 |
| topic_unstemmed |
ddc 610 bkl 44.40 |
| topic_browse |
ddc 610 bkl 44.40 |
| format_facet |
Elektronische Aufsätze Aufsätze Elektronische Ressource |
| format_main_str_mv |
Text Zeitschrift/Artikel |
| carriertype_str_mv |
zu |
| author2_variant |
a r w ar arw b s bs m c mc |
| hierarchy_parent_title |
Local Control After Stereotactic Radiosurgery (SRS) for Brain Metastases (BM) in Melanoma Patients With and Without BRAF Mutation and Treatment |
| hierarchy_parent_id |
ELV011527242 |
| dewey-tens |
610 - Medicine & health |
| hierarchy_top_title |
Local Control After Stereotactic Radiosurgery (SRS) for Brain Metastases (BM) in Melanoma Patients With and Without BRAF Mutation and Treatment |
| isfreeaccess_txt |
false |
| familylinks_str_mv |
(DE-627)ELV011527242 |
| title |
Who stays in medication treatment for opioid use disorder? A national study of outpatient specialty treatment settings |
| ctrlnum |
(DE-627)ELV054325544 (ELSEVIER)S0740-5472(21)00055-6 |
| title_full |
Who stays in medication treatment for opioid use disorder? A national study of outpatient specialty treatment settings |
| author_sort |
Krawczyk, Noa |
| journal |
Local Control After Stereotactic Radiosurgery (SRS) for Brain Metastases (BM) in Melanoma Patients With and Without BRAF Mutation and Treatment |
| journalStr |
Local Control After Stereotactic Radiosurgery (SRS) for Brain Metastases (BM) in Melanoma Patients With and Without BRAF Mutation and Treatment |
| lang_code |
eng |
| isOA_bool |
false |
| dewey-hundreds |
600 - Technology |
| recordtype |
marc |
| publishDateSort |
2021 |
| contenttype_str_mv |
zzz |
| container_start_page |
0 |
| author_browse |
Krawczyk, Noa |
| container_volume |
126 |
| class |
610 VZ 44.40 bkl |
| format_se |
Elektronische Aufsätze |
| author-letter |
Krawczyk, Noa |
| doi_str_mv |
10.1016/j.jsat.2021.108329 |
| dewey-full |
610 |
| title_sort |
who stays in medication treatment for opioid use disorder? a national study of outpatient specialty treatment settings |
| title_auth |
Who stays in medication treatment for opioid use disorder? A national study of outpatient specialty treatment settings |
| abstract |
Maintenance treatments with medications for opioid use disorder (MOUD) are highly effective at reducing overdose risk while patients remain in care. However, few patients initiate medication and retention remains a critical challenge across settings. Much remains to be learned about individual and structural factors that influence successful retention, especially among populations dispensed MOUD in outpatient settings. |
| abstractGer |
Maintenance treatments with medications for opioid use disorder (MOUD) are highly effective at reducing overdose risk while patients remain in care. However, few patients initiate medication and retention remains a critical challenge across settings. Much remains to be learned about individual and structural factors that influence successful retention, especially among populations dispensed MOUD in outpatient settings. |
| abstract_unstemmed |
Maintenance treatments with medications for opioid use disorder (MOUD) are highly effective at reducing overdose risk while patients remain in care. However, few patients initiate medication and retention remains a critical challenge across settings. Much remains to be learned about individual and structural factors that influence successful retention, especially among populations dispensed MOUD in outpatient settings. |
| collection_details |
GBV_USEFLAG_U GBV_ELV SYSFLAG_U SSG-OLC-PHA SSG-OPC-PHA GBV_ILN_20 GBV_ILN_30 GBV_ILN_40 |
| title_short |
Who stays in medication treatment for opioid use disorder? A national study of outpatient specialty treatment settings |
| url |
https://doi.org/10.1016/j.jsat.2021.108329 |
| remote_bool |
true |
| author2 |
Williams, Arthur Robin Saloner, Brendan Cerdá, Magdalena |
| author2Str |
Williams, Arthur Robin Saloner, Brendan Cerdá, Magdalena |
| ppnlink |
ELV011527242 |
| mediatype_str_mv |
z |
| isOA_txt |
false |
| hochschulschrift_bool |
false |
| author2_role |
oth oth oth |
| doi_str |
10.1016/j.jsat.2021.108329 |
| up_date |
2024-07-06T21:24:56.978Z |
| _version_ |
1803866443065851904 |
| fullrecord_marcxml |
<?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>01000caa a22002652 4500</leader><controlfield tag="001">ELV054325544</controlfield><controlfield tag="003">DE-627</controlfield><controlfield tag="005">20230624210427.0</controlfield><controlfield tag="007">cr uuu---uuuuu</controlfield><controlfield tag="008">210910s2021 xx |||||o 00| ||eng c</controlfield><datafield tag="024" ind1="7" ind2=" "><subfield code="a">10.1016/j.jsat.2021.108329</subfield><subfield code="2">doi</subfield></datafield><datafield tag="028" ind1="5" ind2="2"><subfield code="a">/cbs_pica/cbs_olc/import_discovery/elsevier/einzuspielen/GBV00000000001417.pica</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-627)ELV054325544</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(ELSEVIER)S0740-5472(21)00055-6</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-627</subfield><subfield code="b">ger</subfield><subfield code="c">DE-627</subfield><subfield code="e">rakwb</subfield></datafield><datafield tag="041" ind1=" " ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="082" ind1="0" ind2="4"><subfield code="a">610</subfield><subfield code="q">VZ</subfield></datafield><datafield tag="082" ind1="0" ind2="4"><subfield code="a">610</subfield><subfield code="q">VZ</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="a">44.40</subfield><subfield code="2">bkl</subfield></datafield><datafield tag="100" ind1="1" ind2=" "><subfield code="a">Krawczyk, Noa</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Who stays in medication treatment for opioid use disorder? A national study of outpatient specialty treatment settings</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="c">2021</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">zzz</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">z</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">zu</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="520" ind1=" " ind2=" "><subfield code="a">Maintenance treatments with medications for opioid use disorder (MOUD) are highly effective at reducing overdose risk while patients remain in care. However, few patients initiate medication and retention remains a critical challenge across settings. Much remains to be learned about individual and structural factors that influence successful retention, especially among populations dispensed MOUD in outpatient settings.</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Williams, Arthur Robin</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Saloner, Brendan</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Cerdá, Magdalena</subfield><subfield code="4">oth</subfield></datafield><datafield tag="773" ind1="0" ind2="8"><subfield code="i">Enthalten in</subfield><subfield code="n">Elsevier Science</subfield><subfield code="t">Local Control After Stereotactic Radiosurgery (SRS) for Brain Metastases (BM) in Melanoma Patients With and Without BRAF Mutation and Treatment</subfield><subfield code="d">2013</subfield><subfield code="g">Amsterdam [u.a.]</subfield><subfield code="w">(DE-627)ELV011527242</subfield></datafield><datafield tag="773" ind1="1" ind2="8"><subfield code="g">volume:126</subfield><subfield code="g">year:2021</subfield><subfield code="g">pages:0</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">https://doi.org/10.1016/j.jsat.2021.108329</subfield><subfield code="3">Volltext</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_USEFLAG_U</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ELV</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SYSFLAG_U</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SSG-OLC-PHA</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SSG-OPC-PHA</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_20</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_30</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_40</subfield></datafield><datafield tag="936" ind1="b" ind2="k"><subfield code="a">44.40</subfield><subfield code="j">Pharmazie</subfield><subfield code="j">Pharmazeutika</subfield><subfield code="q">VZ</subfield></datafield><datafield tag="951" ind1=" " ind2=" "><subfield code="a">AR</subfield></datafield><datafield tag="952" ind1=" " ind2=" "><subfield code="d">126</subfield><subfield code="j">2021</subfield><subfield code="h">0</subfield></datafield></record></collection>
|
| score |
7.4025326 |